secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK:        0001559053
Form:       8-K
Filed at:   2022-03-25T23:59:59+00:00
Accession:  0001559053-22-000012
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Prothena directors/officers adopt 10b5-1 plans for 458,174 expiring options
---------------------------------------------------------------------------

- Options granted in Jan/Mar/Apr 2013 expire in Jan/Mar/Apr 2023; cover 458,174 shares (<1% of outstanding) with exercise prices $6.41-$6.73 per share.
- Directors and executive officers adopted Rule 10b5-1 trading plans to exercise/sell these expiring options.
- Plans allow orderly disposition of options expiring in 2023; transactions will be reported to the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1559053/000155905322000012/0001559053-22-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1559053/000155905322000012/prta-20220325.htm
  HTML page:      https://secwatch.observer/filing/0001559053-22-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer